Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
Keyword(s):
2018 ◽
Keyword(s):
2017 ◽
Vol 166
◽
pp. 16-27
◽
2015 ◽
Vol 89
(9)
◽
pp. 1401-1438
◽
Keyword(s):
2021 ◽
Vol 94
(0)
◽
pp. 2-S17-1
Keyword(s):